Analyst consensus rating
Elevance Health Analyst Rating: Buy
ELV is rated Buy by 21 analysts with a $449.10 target. As of 2026-08-31.
Direct answer
Elevance Health's consensus rating is Buy.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $449.10.
Forecast evidence checked August 31, 2026.
Get free Elevance Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $394.43
- Average price target
- $449.10
- High price target
- $492.00
- Low price target
- $393.00
- Low target gap
- -0.4%
- Target upside
- +13.9%
- High target gap
- +24.7%
- Target range width
- 25.1%
- Consensus rating
- Buy
- Analysts
- 21
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Elevance Health?
Elevance Health has a verified Buy consensus. The same dataset has an average price target of $449.10.
How far are Elevance Health's low and high targets from the recorded price?
The low target implies -0.4%, while the high target implies +24.7%.
How many analysts are included in Elevance Health's consensus?
The verified consensus includes 21 analysts.
How is Elevance Health's target upside or downside calculated?
The average target of $449.10 is divided by the recorded price of $394.43, then one is subtracted to produce +13.9%. This does not guarantee a future return.
When was Elevance Health's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.